LOST PILL, LOST CONTROL: INVESTIGATING NON-ADHERENCE TO ANTIHYPERTENSIVE THERAPY IN HYPERTENSIVE PATIENTS
Main Article Content
Keywords
Hypertension, non-adherence, antihypertensive medications, cardiovascular morbidity, blood pressure control, smoking cessation, adherence predictors, clinical outcomes, essential hypertension, patient-centered interventions.
Abstract
Background: Non-adherence to antihypertensive medications is a significant barrier to achieving optimal blood pressure control and reducing cardiovascular morbidity and mortality. Despite advancements in hypertension management, poor adherence remains a persistent challenge influenced by multiple demographic, clinical, and behavioral factors.
Objective: This single-center prospective cohort study aimed to identify predictors of non-adherence to antihypertensive medications and evaluate their impact on clinical outcomes in patients with essential hypertension.
Methods: This study included 350 participants recruited from a tertiary care hospital in Pakistan. Data were collected through structured interviews, clinical evaluations, and reviews of medical and pharmacy records. Adherence was assessed using patient self-reports, pharmacy refill data, and clinical documentation. Demographic and clinical variables, including age, sex, smoking status, diabetes, and BMI, were analyzed. Multivariate logistic regression was employed to identify predictors of non-adherence, while clinical outcomes were evaluated using comparative statistical analyses.
Results: Non-adherence was observed in 24.3% of the participants and was significantly associated with older age, male sex, and smoking status. Adherent participants demonstrated better blood pressure control (78.6% achieving target BP <140/90 mmHg vs. 48.2%, p < 0.001) and lower hospitalization rates (9.2% vs. 23.5%, p < 0.001) than non-adherent participants. Multivariate logistic regression identified smoking as the strongest predictor of non-adherence (OR: 2.45; 95% CI: 1.72–3.12, p < 0.001).
Conclusion: This study highlights the significant impact of non-adherence on clinical outcomes in patients with essential hypertension. These findings underscore the importance of addressing modifiable risk factors, such as smoking, through targeted, patient-centered interventions. By improving adherence, healthcare providers can optimize hypertension management and reduce the burden of hypertension-related complications.
References
2. Mills, K. T., Stefanescu, A., & He, J. (2020). The global epidemiology of hypertension. Nature Reviews Nephrology, 16(4), 223–237. https://doi.org/10.1038/s41581-019-0244-2
3. Oparil, S. (2014). Low Sodium Intake — Cardiovascular Health Benefit or Risk? New England Journal of Medicine, 371(7), 677–679
4. Whelton PK, Carey RM, Aronow WS, et al.: 2017 ACC/AHA guideline for teh prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018, 71:127-248. 10.1001/jama.2017.18209IF: 63.1 Q1
5. Burnier M, Egan BM: Adherence in hypertension: A review of prevalence, risk factors, impact, and management. Circ Res. 2019, 124:1124-1140. 10.1161/CIRCRESAHA.118.313220IF: 16.5 Q1
6. Dragomir, A., Lalonde, L., Roy, L., Blais, L., Bérard, A., Côté, R., & Perreault, S. (2010). Impact of Adherence to Antihypertensive Agents on Clinical Outcomes and Hospitalization Costs. Medical Care, 48(5), 418–425. https://doi.org/10.1097/mlr.0b013e3181d567bd
7. Nieuwlaat R, Wilczynski N, Navarro T, et al.: Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014, 11:10.1002/14651858.CD000011.pub4IF: 8.8 Q1
8. Krousel-Wood M, Thomas S, Muntner P, et al.: Medication adherence: A key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004, 19:357-362. 10.1097/01.hco.0000134353.82580.96
9. Kamran A, Ahari SS, Biria M, et al.: Determinants of patient adherence to antihypertensive medications: Application of health belief model among rural patients. Ann Med Health Sci Res. 2014, 4:922-927. 10.4103/2141-9248.144914
10. Mazzaglia G, Ambrosioni E, Alacqua M, et al.: Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009, 120:1598-1605. 10.1161/CIRCULATIONAHA.108.830299IF: 35.5 Q1
11. Chow CK, Teo KK, Rangarajan S, et al.: Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013, 310:959-968. 10.1001/jama.2013.184182IF: 63.1 Q1
12. Mills KT, Bundy JD, Kelly TN, et al.: Global disparities of hypertension prevalence and control: A systematic analysis of population-based studies from 90 countries. Circulation. 2016, 134:441-450. 10.1161/CIRCULATIONAHA.115.018912IF: 35.5 Q1
13. Sabate E: Adherence to Long-term Therapies: Evidence for Action. World Health Organization. 2003, 10.1111/j.1547-5069.2003.tb00001.xIF: 2.4 Q1
14. Kini V, Ho PM: Interventions to improve medication adherence: A review. JAMA. 2018, 320:2461-2473. 10.1001/jama.2018.19271IF: 63.1 Q1
15. Zolnierek KB, DiMatteo MR: Physician communication and patient adherence to treatment: A meta-analysis. Med Care. 2009, 47:826-834. 10.1097/MLR.0b013e31819a5accIF: 3.3 Q1
16. Kronish IM, Ye S: Adherence to cardiovascular medications: Lessons learned and future directions. Prog Cardiovasc Dis. 2013, 55:590-600. 10.1016/j.pcad.2013.02.001IF: 5.6 Q1